한국식품영양과학회지 (Journal of the Korean Society of Food Science and Nutrition)

  • 제38권2호
  • /
  • Pages.177-181
  • /
  • 2009
  • /
  • 1226-3311(pISSN)
  • /
  • 2288-5978(eISSN)
한국식품영양과학회 (The Korean Society of Food Science and Nutrition)
권호 표지
DOI QR코드

DOI QR Code

Aroase AP10에 의한 문어 가수분해물의 Angiotensin Converting Enzyme 저해 Peptide의 특성

Characteristics of Angiotensin Converting Enzyme Inhibitory Peptides from Aroase AP10 Hydrolysate of Octopus

  • 박영범 (강원도립대학 식품가공제과제빵과)
  • 발행 : 2009.02.28
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

문어육의 Aroase AP10 가수분해물을 제조하고 이들 가수분해물을 한외여과막을 통과시켜 회수한 분자량 10,000 Da이하의 저분자물질을 Bio-gel P-2 gel chromatography를 행하여 ACE 저해효과를 가지는 3개 획분을 분취하였다. 또한 이들 획분을 SuperQ-Toyopearl 650S column을 이용한 이온교환크로마토그래피에 의해 4개의 활성획분을 분리하였다. 이중 ACE 저해효과가 가장 높은 C-1 획분의 아미노산 조성은 arginine, lysine, histidine 및 leucine의 함량이 가장 많아 전체의 약 60%를 차지하였으며 $IC_{50}$은 $3.10{\mu}g$으로 나타났다.

The peptides from Aroase AP10 enzymatic hydrolysates of octopus proteins were isolated and tested for inhibitory activity against angiotensin converting enzyme (ACE). The Aroase AP10 hydrolysates were filtered through PM-10 membrane (M.W. cut-off 10,000) to obtain the peptides fractions with ACE inhibition activity. These fractions were applied to a Biogel P-2 column. Three active fractions (A, B, and C) were collected and applied to a SuperQ-Toyopearl 650S column chromatography, leading to the isolation of four active fractions (A-1, A-2, B-1, and C-1). Among the active fractions, C-1 had the highest ACE inhibitory activity ($IC_{50}=3.10{\mu}g$). The main composition of its amino acids is arginine, lysine, histidine and leucine, which cover about 60% of the total amino acids.

키워드

참고문헌

  1. Frohlich ED. 1982. Hemodynamic factors in the pathogenesis and maintenance of hypertension. Fed Proc Fed Am Soc Exp Biol 41: 2400-2408
  2. Esther CR, Marino Jr EM, Bernstein KE. 1997. The role of angiotensin-converting enzyme in blood pressure control, renal function and male fertility. Trends Endocrinol Metab 8: 181-186 https://doi.org/10.1016/S1043-2760(97)00039-8
  3. Lapointe N, Rouleau JL. 2002. Activation of vascular tissue angiotensin-converting enzyme (ACE) in heart failure. J Am Coll Cardiol 39: 776-779 https://doi.org/10.1016/S0735-1097(01)01830-7
  4. Unger T. 2002. The role of the renin-angiotensin system in the development of cardiovascular disease. Am J Cardiol 89: 3A-10A https://doi.org/10.1016/S0002-9149(01)02321-9
  5. Ondette MA, Cushman DW. 1982. Enzymes of the renin-angiotensin system and their inhibitors. Ann Rev Biochem 51: 283-308 https://doi.org/10.1146/annurev.bi.51.070182.001435
  6. Murphey L, Vaughan D, Brown N. 2003. Contribution of bradykinin to the cardioprotective effects of ACE inhibitors. European Heart J Suppl 5: A37-A41 https://doi.org/10.1016/S1520-765X(03)90062-9
  7. Soffer RL. 1976. Angiotensin-converting enzyme and the regulation of vasoative peptides. Annu Rev Biochem 45: 73-94 https://doi.org/10.1146/annurev.bi.45.070176.000445
  8. Ferreria SH, Diana CB, Greene LJ. 1983. Isolation of bradykinin-potentiating peptides from Bothrops jararaca venom. Biochemistry 9: 2583-2593 https://doi.org/10.1021/bi00815a005
  9. Atkinson AB, Robertson JIS. 1979. Captopril in the treatment of clinical hypertension and cardiac failure. Lancet Neurology 2: 836-839
  10. Lee HJ, Kim YS, Chang Y, Lee JR, Yun-Choi HS. 1984. Synthesis of angiotensin converting enzyme inhibitors. Yakhak Hoeji 28: 313-319
  11. Mark KS, Davis TP. 2000. Development, prevention and treatment with peptides inhibitor. Peptides 21: 1965-1793 https://doi.org/10.1016/S0196-9781(00)00346-6
  12. Suzuki T, Ishikawa N, Meguro H. 1983. Angiotensin I-converting enzyme inhibition activity in foods. Nippon Nogeikagaku Kaishi 57: 1143-1146 https://doi.org/10.1271/nogeikagaku1924.57.1143
  13. Yamamoto N, Akino A, Takano T. 1994. Antihypertensive effect of the peptides derived from casein by an extracellular proteinase from Lactobacillus helverticus CP790. J Dairy Sci 77: 917-922 https://doi.org/10.3168/jds.S0022-0302(94)77026-0
  14. Yano S, Suzuki K, Gunatsu G. 1996. Isolation from a-zein of thermolsin peptides with angiotensin I-converting enzyme inhibitory activity. Biosci Biotech Biochem 60: 661-663 https://doi.org/10.1271/bbb.60.661
  15. Kuba M, Tanaka K, Tawata S, Takeda Y. 2003. Angiotensin I-converting enzyme inhibitory peptides isolated from Tofuyo fermented soybean food. Biosci Biotech Biochem 67: 1278-1283 https://doi.org/10.1271/bbb.67.1278
  16. Zhu XL, Watanabe K, Shiraishi K. 2008. Identification of ACE-inhibitory peptides in salt-free soysauce that are transportable across caco-2 cell monolayers. Peptides 29: 338-344 https://doi.org/10.1016/j.peptides.2007.11.006
  17. Do JR. 2000. Separation and purification of angiotensin I-converting enzyme inhibitory peptide from mackerel. J Korean Fish Soc 33: 153-157
  18. Choi YR, Park PJ, Choi JH, Byun HG, Jeong IC, Moon SH, Kim SK. 2000. Purification and characterization of angiotensin I converting enzyme inhibitory peptides from enzymatic hydrolysate of cod liver protein. Korean J Life Sci 10: 140-149
  19. Suh HJ, Cho SJ, Whang JH, Lee H, Yang HC. 1997. Characterization of angiotensin converting enzyme inhibitor from squid hydrolysate. Food and Biotech 6: 122-124
  20. Kim TJ, Yoon HD, Lee YS. 1996. Angiotensin-I converting enzyme inhibitory activity of hot-water extract and enzymatic hydrolysate of fresh water fish. J Korean Soc Food Sci Nutr 25: 871-877
  21. Lee HO, Kim DS, Do JR, Kwan DY. 2001. Separation and purification of angiotensin-I converting enzyme inhibitory peptides from laver hydrolysate. J Korean Fish Soc 34: 164-172
  22. Ariyoshi Y. 1993. Angiotensin-converting enzyme inhibitors derived from food proteins. Trends Food Sci Technol 4: 139-144 https://doi.org/10.1016/0924-2244(93)90033-7
  23. Shin ZI, Ahn CW, Nam HS, Lee HJ, Moon TH. 1995. Fractionation of angiotensin converting enzyme (ACE) inhibitory peptides from soybean paste. Korean J Food Sci Technol 27: 230-234
  24. Suetsuna K, Yamagami M, Kuwata K. 1988. Inhibitory activity against angiotensin I-converting enzyme of peptides originating from fish and shellfish muscle. Nippon Suisan Gakkaishi 54: 1853-1858 https://doi.org/10.2331/suisan.54.1853
  25. Yeum DM, Lee TG, Byun HS, Kim SB, Park YH. 1992. Angiotensin-I converting enzyme inhibitory activity of enzymeatic hydrolysates of mackerel muscle protein. Bull Korean Fish Soc 25: 229-235
  26. Cheung HS, Wang FL, Ondetti MA, Sabo FF, Cushman DW. 1980. Binding-of peptide substrates and inhibitors of angiotensin-I converting enzyme, importance of the COOHterminal dipeptide sequence. J Biol Chem 255: 401- 407
  27. Maruyama S, Niyoshi S, Tanaka H. 1989. Angiotensin-I converting enzyme inhibitor derived from ficus carica. Agric Biol Chem 53: 2763-2767 https://doi.org/10.1271/bbb1961.53.2763
  28. Matsumura N, Fujii M, Takeda Y, Shimizu T. 1993. Isolation and characterization of angiotensin I-converting enzyme inhibitory peptides derived form bonito bowels. Biosci Biotech Biochem 57: 1743-1744 https://doi.org/10.1271/bbb.57.1743

피인용 문헌

  1. Quality Characteristics and Antioxidative Activities of Acorn Starch Mook Added Spirulina and Soy Protein vol.41, pp.11, 2012, https://doi.org/10.3746/jkfn.2012.41.11.1515
  2. Development of antihypertensive natural seasoning using beef hydrolyzate vol.56, pp.2, 2013, https://doi.org/10.1007/s13765-011-3023-8
  3. Effect of Angiotensin-I Converting Enzyme Inhibitory from Hydrolysate of Soybean Protein Isolate vol.39, pp.1, 2010, https://doi.org/10.3746/jkfn.2010.39.1.008
  4. Angiotensin-Converting Enzyme Inhibitory Activity of Enzymatic Hydrolysates of Crassostrea gigas (Oyster) vol.22, pp.2, 2012, https://doi.org/10.5352/JLS.2012.22.2.220
  5. Angiotensin I Converting Enzyme Inhibitory Effects of Gelatin Hydrolysates Prepared from Tilapia mossambica Scales by Hot Water and Enzymatic Extraction vol.42, pp.5, 2009, https://doi.org/10.5657/kfas.2009.42.5.426